← FDA DRUG APPROVALS

FDA NDA · NDA022214

ARIMIDEX

Sponsor: ASTRAZENECA

APPLICATION
NDA022214
TYPE
NDA
ORIGINAL APPROVAL
2008-12-05
LATEST ACTION
2008-12-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ARIMIDEXPrescription
ANASTROZOLE 1MG · TABLET · ORAL

Approval history

2008-12-05Type 6 - New Indication (no longer used) · Original · priorityPediatric Medical ReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →